Press releaseGlobe Newswire
Launch One Acquisition
LPAA · NASDAQ
$10.87−$0.01 (−0.09%)TodayMarket closed ·
Prev close $10.88
Latest news
- Press releaseGlobe Newswire
Minovia Therapeutics Mitochondrial Augmentation Technology to be Featured in Presentation and Workshop at the 67th ASH Annual Meeting and Exposition
- Press releaseGlobe Newswire
Minovia Therapeutics Receives FDA Orphan Drug Designation for MNV-201 in Myelodysplastic Syndrome
- Press releaseGlobe Newswire
Minovia Therapeutics Receives FDA Fast Track Designation for MNV-201 in Myelodysplastic Syndrome
- Press releaseGlobe Newswire
Minovia Therapeutics Announces $350,000 Grant from Countdown for a Cure Foundation to Develop Mitochondria Blood-Based Biomarkers
- Press releasePRNewswire
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: ATMCR, CRTAF, LPAA, and AFJKU
- Press releaseGlobe Newswire
Minovia Therapeutics Announces FDA Fast Track and Rare Pediatric Disease Designations for MNV-201 in Pearson Syndrome
- News
Minovia Therapeutics To Go Public Via Merger With Launch One Acquisition Corp., Forming Mito US One Ltd. To Advance Mitochondrial Therapies
- Press releaseGlobe Newswire
Minovia Therapeutics Ltd. and Launch One Acquisition Corp. Announce Proposed Business Combination to Create Nasdaq-Listed Mitochondrial Therapy Company in $1 Trillion+ Mitochondrial and Longevity Markets
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.